Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000919574-25-005609·KINGDON CAPITAL MANAGEMENT, L.L.C.
Schedule 13G ownership disclosure
ENVVENO MEDICAL CORPORATION
Common Stock, $0.00001 par value · CUSIP: 29415J106
Event date: 2025-09-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Kingdon Capital Management, L.L.C.
Shares: 1,359,261.00 · Class: 7.1%
- M. Kingdon Offshore Master Fund, L.P.
Shares: 1,265,845.00 · Class: 6.6%
- Kingdon GP, LLC
Shares: 1,265,845.00 · Class: 6.6%
- Mark Kingdon
Shares: 1,359,261.00 · Class: 7.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-005609
- Form type
- SCHEDULE 13G
- Filer
- KINGDON CAPITAL MANAGEMENT, L.L.C.
- CIK
- CIK 1000097
- Filed
- Sep 09, 2025
- Reporting period
- Sep 02, 2025
- Description
- Schedule 13G beneficial ownership